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Two main high-density lipoprotein subfractions, HDL2 and HDL3,
were spin labelled with TEMPO which partitions both in aqueous
and lipid phase. The dynamics of the lipid phase was monitored via
the reduction of incorporated TEMPO with ascorbic acid. The re-
duction of the paramagnetic nitroxide into the nonparamagnetic hy-
droxilamine form decreases the ESR signal with time. The reduc-
tion curves show complex behaviour while the partition coefficients
of TEMPO remain unchanged during the reaction. The reduction
process in the samples containing HDL particles proceeds faster than
in the aqueous solution of pure reactants, e.g. spin label and ascor-
bic acid. In order to explain experimental data the model for reduc-
tion of TEMPO by ascorbic acid is proposed. It assumes that the
processes taking place in these heterogeneous systems are deter-
mined by the overall reaction rate, which depends on the local con-
centrations of the reactants, as well as on their transport proper-
ties in the particular phases.
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INTRODUCTION
Ever since the close interrelation between atherogenesis and disorders
of lipid metabolism has been proven, the molecular structure and function
interdependence in lipoprotein particles has been of great interest.1,2
The spectroscopic studies led to the generally accepted model for all lipo-
protein particles, the so-called »oil drop model«.3 The core of neutral lipids
(triacylglycerols and cholesteryl esters) is encapsulated by an amphipathic
monolayer of polar lipids (phospholipids and cholesterol). The thickness of
the monolayer is determined by the length of acyl chains of phospholipids
and is similar in different lipoprotein particles. As a consequence, in smaller
lipoprotein particles the polar phospholipid heads are more apart, leaving
space for water molecules to be included into the monolayer. The amphipat-
hic protein, which embraces the particle by the hydrophobic interaction with
phospholipid, assures the stability of the structure, but does not penetrate
into the monolayer more than half its depth.4 The smaller the lipoprotein
particle, the larger is the protein/lipid weight ratio. None of the lipoprotein
fractions in the serum is homogeneous with respect to the unique chemical
composition. The reason is in the design of these macromolecular entities
that are responsible for the mass transport so that the catabolic process con-
trols the content and the structure of individual particle.
High-density lipoprotein (HDL) is the smallest and the most abundant
human plasma lipoprotein. It has a major role in reverse cholesterol trans-
port. HDL is a heterogeneous group of particles5,6 and the clinical signifi-
cance differs with the subclasses. Different separation methods define slightly
different subclasses according to physicochemical properties. It is common to
define two main HDL subfractions HDL2 and HDL3. There are similarities
in structure of these particles: predominance of monolayer over core volume,
high protein/lipid ratio and higher content of polar over neutral lipids7,8,9
but at the same time there is a great functional diversity especially with re-
spect to the coronary heart disease.10 It is the concentration of HDL2 parti-
cle in blood that shows the inverse relationship to the incidence of athero-
sclerosis.
Here we report the study of nitroxide reduction with ascorbic acid in spin
labelled human HDL2 and HDL3 in order to examine the dynamics of parti-
cles surfaces, which could play a role in their physiological function.
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EXPERIMENTAL
Lipoprotein Isolation
The human serum lipoproteins in the density range of 1.063–1.125 g/cm3 (HDL2)
and 1.125–1.21 g/cm3 (HDL3) have been isolated by sequential ultracentrifugation of
fresh-drawn plasma from four normolipidemic female donors as already described.11
The purity of the lipoprotein samples was checked by electrophoresis and the con-
centrations of lipoprotein solutions were determined gravimetrically.
The spin label TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl) was synthesized ac-
cording to the published procedure.12
Chromium oxalate was prepared according to Berg and Nesbitt 1979.13
Ascorbic acid was purchased from Pliva Chemical Company. For each experiment
it was dissolved in the buffer immediately before the measurement.
The lipoprotein samples and all the dilutions in the experiments were performed
in 0.1 mol/L Tris-HCl buffer, pH = 7.4 with 1 g/L of EDTA except chromium oxalate.
It was prepared in distilled water to match the physiological osmolarity.
Spin Labelling of Lipoproteins
To perform a comparative study of two HDL subfractions, the concentration of
both lipoprotein samples was adjusted such that the estimated concentration of the
monolayer lipids was 0.02 mol/L. TEMPO dissolved in Tris-HCl buffer was added to
the lipoprotein suspension. The molar ratio of TEMPO dissolved in lipoproteins ver-
sus surface lipid content was kept approximately 1 : 50. The equilibrium distribution
of TEMPO was reached within 30 minutes, as independently checked by monitoring
the time dependence of ESR signal over a longer period of time.
Analysis of Fatty Acid Composition
In order to define chemical structure characteristics of the HDL particles the ana-
lysis of fatty acid composition of phospholipids, triacylglycerols and cholesteryl es-
ters was performed according to the published procedure.14,15
Chromium Oxalate Measurements
The paramagnetic agent chromium oxalate was added to the spin labelled lipo-
protein solutions in order to prove that TEMPO does partition in HDL particles. The
consequence of the interaction between TEMPO and chromium oxalate is the line
broadening of the ESR spectrum. Since chromium oxalate does not penetrate into
the HDL particle, the remaining component in the spectrum is assigned to the spin
label molecules dissolved in the lipid phase of HDL, as confirmed by hyperfine split-
ting. In the final solution the concentration of chromium oxalate was 60 mmol/L.
Nitroxide Reduction with Ascorbic Acid
The kinetics of the nitroxide reduction with ascorbic acid monitors the dynamics
of the lipid phase of two high-density lipoprotein subfractions. For that purpose the
concentration of the ascorbic acid versus TEMPO was in nearly threefold excess. The
process was followed by the decrease in the intensity of ESR spectra that were nor-
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malised to the strong pitch standard. The spectrum at zero time was obtained with
the lipoprotein sample in which the aliquot of buffer instead of ascorbic acid was
added. The intrinsic reduction rate of TEMPO with ascorbic acid was deduced from
measurements in the pure mixture of reactants.
ESR Spectroscopy
All spectra were recorded at (37  1) °C with Varian E-109 ESR spectrometer,
operating at: frequency 9.62 GHz, microwave power 10 mW, modulation amplitude
0.1 mT and modulation frequency 100 kHz. The acquisition of ESR spectra was per-
formed using EW Scientific Software Service program.16
For the data analysis the simulation of experimental spectra was performed with
two superimposed Gaussian type spectra. The ESR spectrum, S, was presented as a
superimposition of the spectra corresponding to the spin probe residing in the hydro-
phobic (Sh) and hydrophilic (Sp) environments:
S = fT Sh + (1 – fT)Sp (1)
where fT, the partition parameter, denotes the contribution of the hydrophobic com-
ponent in the total ESR spectrum.17
RESULTS
Chemical Composition of Lipids
The result of chemical composition analysis of fatty acids (FA) in HDL2
and HDL3 particles is presented in Table I. In the first part (Table Ia) the
abundance of certain FA is expressed as its mole fraction towards the total
amount of all FA. In the second part (Table Ib) the data are presented as the
mole fraction of the specific FA in the core or in the monolayer with respect
to the total amount of that particular FA per lipoprotein particle. The calcu-
lation was performed according to the oil-drop model. Namely, the FA of tri-
acylglycerol and cholesteryl ester are presented as a content of the core, while
the FA of phospholipids are attributed to the monolayer. In the analysis of
FA content the distribution of unsaturated FA between the monolayer and
the core is extremely important due to their ability to disturb the lipid pack-
ing in the observed phase.18 Our analysis demonstrates (Table Ia) a balance
in the content of saturated versus unsaturated FA pro HDL2 particle. Re-
garding their distribution between the monolayer and the core it is evident
(Table Ib) that the majority of the unsaturated FA constitutes the core lipids
while leaving saturated FA predominantly in the monolayer.
In HDL3 particle 66% are unsaturated FA, almost equally distributed betwe-
en the surface monolayer and the core (Table I). Therefore, in comparison
with HDL2 in HDL3 particle one would expect a less ordered, more fluid mo-
nolayer.19 It should be also stressed that the substantial part of the mono-
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layer volume is occupied by the apoproteins. It is generally accepted20 that
HDL apoproteins intrude into the lipid phase with 2/3 of their volumes so
that protein/lipid hydrophobic interactions are to be considered when dis-
cussing the kinetics taking place at the surface of these lipoproteins.21
Spin Label Partitioning in HDL
The ESR spectra of TEMPO dissolved in lipoprotein solutions are pre-
sented on Figure 1. The complex experimental spectra have been resolved
via theoretical simulation described previously.17 The component with larger
hyperfine splitting is ascribed to TEMPO dissolved in the polar environment,
while the one with smaller hyperfine splitting is attributed to the probe mo-
lecules dissolved in lipid part of lipoprotein particle. The spectrum of that
component was achieved in the experiment with fast relaxing paramagnetic
agent (Figure 1, Insert). The theoretical simulations of the equilibrium
spectra resulted in the partition parameters defined in (1): fT = 0.20 and
fT = 0.28 for HDL2 and HDL3, respectively.
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TABLE I
Analysis of fatty acid contents in HDL2 and HDL3 particles
a) Composition of FA (mole fractions/%) per lipoprotein particle
Lipoprotein
Fatty acid
14 : 0 16 : 0 18 : 0 16 : 1 18 : 1 18 : 2 18 : 3 20 : 4 22 : 6 Total
HDL2 3.66 32.94 13.60 4.22 20.83 20.75 3.98 99.98
HDL3 0.98 27.10 11.58 4.20 22.84 30.24 0.20 2.58 0.20 99.92
b) Relative distribution of FA (mole fractions/%) between the monolayer and the
core per lipoprotein particle
Fatty acid
14 : 0 16 : 0 18 : 0 16 : 1 18 : 1 18 : 2 18 : 3 20 : 4 22 : 6
HDL2
Monolayer 72.85 93.20 27.03 9.02
Core 100 27.15 6.8 100 72.96 100 90.99
Total 100 100 100 100 100 100 100
HDL3
Monolayer 69.75 72.95 91.61 25.72 48.03 43.27 84.77 100
Core 30.25 29.05 8.4 74.27 51.97 57.73 100 15.23
Total 100 100 100 100 100 100 100 100 100
Reduction of TEMPO by Ascorbic Acid
The ascorbic acid was used to monitor the dynamics of TEMPO equili-
bration in lipoproteins exposed to the nonequilibrium conditions. The para-
magnetic nitroxide is reduced to the nonparamagnetic hydroxylamine form
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Figure 1. The equilibrium spectra of TEMPO partitioning in HDL2 and HDL3. The
experimental spectra are presented with a full line whereas the theoretical simula-
tions are depicted with the dotted line. The following concentrations were used in the
experiments: c(TEMPO) = 0.41 mmol/L; c(HDL2) = 0.127 mmol/L; c(HDL3) = 0.334 mmol/L.
The fitting parameters are:
a) polar component for both lipoproteins: c = 0.01 ns, linewidth of the central peak
= 0.13 mT, hyperfine splitting = 1.72 mT and g factor = 2.0023;
b) hydrophobic part for HDL2: c = 0.03 ns, linewidth = 0.17 mT, hyperfine split-
ting = 1.58 mT, g factor = 2.0027 and fT = 0.20; for HDL3: c = 0.03 ns, linewidth
= 0.18 mT, hyperfine splitting = 1.57 mT, g factor = 2.0028 and fT = 0.28.
The insert: the spectra of TEMPO dissolved in the lipid phase of HDL particles in
the presence of chromium oxalate in the lipoprotein solutions.
in the reaction with ascorbic acid and therefore the ESR signal of TEMPO
decreases with time (Figure 2). The time course of TEMPO reduction with
ascorbic acid is presented on Figure 3. It is interesting to note that the reac-
tion proceeds faster in the samples containing HDL particles as compared to
the pure mixture of reactants (spin label and ascorbic acid). At the same
time the partition parameter of TEMPO stays unchanged during the reduc-
tion in both lipoprotein solutions.
Model for TEMPO Reduction in HDL Solution
The complex reduction kinetics of TEMPO in HDL solutions is simula-
ted by the set of coupled differential equations. Here the simultaneous pro-
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Figure 2. The ESR spectra of nitroxide reduction with ascorbic acid in spin labelled
HDL2 and HDL3 solutions. The full line represents the control spectra without as-
corbic acid. Dashed (dotted) lines denote spectra 2 (12) minutes after the addition of
ascorbate, respectively.
cesses taking place in the heterogeneous system should be considered. For
the comparison, even in the pure system of TEMPO and ascorbic acid the
disappearance of the spin label signal depends on three parallel reactions:
SL* + A  SLH + DHA, SLH + O2  SL
* and A + O2  DHA.
22 We denoted
spin probe (nitroxide) with SL* and its reduced form (hydroxylamine) with
SLH, while A stays for ascorbate and DHA for dehydroascorbate. The domi-
nant spin probe reduction is modulated by oxidation of hydroxylamine, as
well as by the oxidation of ascorbic acid in areobic conditions. The equations
which satisfactorily describe the proposed reactions in the homogeneous mix-
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where cSL, cO 2 and cA are the concentrations of TEMPO, oxygen and ascorbic
acid in the aqueous solution, respectively. The starting concentrations were
cSL(t = 0) = cSL0 = 0.4  10
–3 mol/L, cO 2 (t = 0) = 2  10
–4 mol/L and cA(t = 0)
= 1.1  10–3 mol/L. Free parameters in the model, k1, k2 and k3 are deter-
mined from the best fit of the experimental data.
To extend the model for reduction of spin probe in the homogeneous so-
lution to the samples containing HDL particles, the coexistence of spin label
in two environments with different reduction rates was assumed. The sys-
tem of diferential equations (3) describes the reactions taking place paralle-
ly in the aqueous solution and in the particles. The overall reduction rate
should depend on the local concentrations of reactants as well as on their
transport parameters for the particular phase. We also assume that, due to
the hydrophobicity of the lipoprotein particle interior, there could be an al-
teration in local concentrations of the reactants within as well as on the sur-
face of the particle. Therefore, the set of equations describing the reduction
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where cSLm , cSLHm and cO 2m are the concentrations of TEMPO, its hydroxyl-
amine form and oxygen in the lipid phase, respectively. ,  and  denote the
exchange rates coefficients for SL*, SLH and oxygen between aqueous solu-
tion and lipoprotein respectively. The spin probe reduction and oxidation of
hydroxylamine in the lipid phase was described by reactions rate coeffi-
cients  and k4. Partition coefficient  is defined by equation (4) as the con-
centration ratio of the spin probe in the particle monolayer against the
aqueous solution. The volumes were calculated from the experimental con-
centration of the lipoprotein particles and the intensity ratio fT was calcu-
lated from the spectrum in Figure 1. From the best fit of the Eqs. (3) to the
experimental data we obtained four parameters k4, ,  and  while k1, k2
and k3 were taken from the reduction kinetics in the homogeneous mixture
of reactants. The rate constant  was estimated according to the data from
CRC Handbook of Biochemistry.23 These data are summarised in Table II
and presented in Figure 3. It turned out that the rate constant (k1), describ-
ing the reduction of TEMPO in the pure aqueous solution is smaller than ,
describing the same process taking place in the surface monolayer of both li-
poprotein particles. Comparing the two HDL particles it can be noticed that
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all free parameters in the simulation of the experimental data are signifi-
cantly smaller for HDL3 with respect to HDL2 particle in framework of the
t-test statistics.
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Figure 3. The reduction of TEMPO by ascorbic acid in spin labelled HDL2 (a) and
HDL3 (b) suspensions.
The following are the concentrations of reactants in the experiments: c(TEMPO) =
0.41 mmol/L, c(HDL2) = 0.127 mmol/L, c(HDL3) = 0.334 mmol/L, c(ascorbic acid) =
1.2 mmol/L. Symbols represent experimental ESR intensities, I(t), normalised to the
starting intensity, I(t = 0), which are derived as averaged values from the four inde-
pendent measurements. With the full lines the result of the theoretical simulation
according to Eqs. (2) and (3) are shown.
DISCUSSION
We have studied the reduction of spin probe TEMPO with ascorbic acid
in lipoprotein solutions.
The main result of our experiments indicates that in the presence of
HDL2 and HDL3 particles the reduction rate of the nitroxide is enhanced as
compared to the control process without the particles. During the experi-
ment the partition of TEMPO between the lipoprotein particles and the
aqueous solution remained unchanged.
To understand the observed phenomenon we applied the mathematical
modeling of the complex reaction kinetics taking place in the heterogeneous
biological system.
The possibility that HDL itself reduces TEMPO and accelerates the dis-
appearence of ESR spectra had to be excluded since there was no reduction
in the labeled HDL in absence of ascorbate.
Therefore, we considered that the overall kinetics results from a series
of parallel coupled processes, taking place in the two environments (polar/
nonpolar), characterised by specific rate constants. The fact that the parti-
tion coefficient stays unchanged during the reduction in both lipoproteins
supports the assumption of a fast spin probe exchange between the aqueous
solution and the particles.
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TABLE II
The rate constants used in the simulation of the experimental data
HDL2 HDL3
Rate constant
k1/(L / mol min) a 90  10 90  10
k2/(L / mol min) a 90  10 90  10
k3/(L / mol min) b 0.01 0.01
k4/(L / mol min) c 150  10 30  7
/(1/min) c 150  50 70  30
/(1/min) c 150  50 70  30
/(1/min) b 20 20
 7.8 8.1
O2 4 4
/(L / mol min) c 220  6 170  6
a Determined in the framework of the model described by Eqs. (2).
b Acording to the data from CRC Handbook of Biochemistry.23
c Determined in the framework of the model described by Eqs. (3).
Undoubtedly, the observed enhanced reduction kinetics in HDL is a con-
sequence of high reduction rates in the hydrophobic environment of the lipid
phase. One possible explanation of this phenomenon is the way of insertion
of TEMPO molecule into the surface monolayer. We assume that the nitro-
xide group of TEMPO molecule is facing preferentially the aqueous phase.
This convenient orientation could increase the efficiency of encounters with
ascorbate. Besides, the positively charged lipoprotein surface might induce
a local concentration increase of ascorbate anion at the surface of the parti-
cle.
The higher values of the oxidation rate constants of reactions taking place
in the HDL2 as compared with the oxidation in the aqueous phase might
also be due to the higher oxygen solubility in the hydrophobic reaction ma-
trix.
We have also observed remarkable differences in the rate constants of
reactions taking part in the HDL2 and HDL3 particles (Table II). Both, the
reductions as well as the oxidation rate constants are larger for the HDL2
particles. This observation can be confronted with the difference in the cur-
vature of the surface and the content of the unsaturated fatty acids of the
monolayer. The smaller HDL3 particle monolayer exhibits larger curvature
and has a higher content of the unsaturated fatty acids (Table I). Therefore,
we may assume that it is more exposed to the polar surroundings and thus
imposes less structural restrictions for the reaction kinetics to proceed.24,25
Comparing  and  coefficients for HDL2 and HDL3 a twofold faster pro-
cess in HDL2 than in HDL3 can be deduced (Table II). The explanation of
this phenomenon should be searched in the specificity of apoprotein/phos-
pholipids intermolecular forces. Besides, the depth of the hydration layer is
determined by the content of unsaturated fatty acids and cholesterol. In
HDL2 the fraction of unsaturated fatty acids is smaller than in HDL3 and
distributed mainly in the core (Table I). On the other hand, the high content
of unsaturated FA and protein in the HDL3 monolayer results in smaller hy-
drophobic barriers.26 The interface between the particle’s monolayer and the
aqueous solution is therefore for HDL3 characterised with less effective re-
activity, which might in part relay on the deeper penetration of water mole-
cules into the monolayer by which the ordering dependent dynamic struc-
ture is perturbed.
CONCLUSION
HDL particles are involved as the carriers of hydrophobic molecules in
the systemic circulation. The autooxidant activity or interactions of trans-
ported molecules with other oxidant substances could be dramatically en-
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hanced either via local concentration increase or by their exposure on the li-
poprotein surface what enables the reaction.
We have observed that the solubilisation of the ambivalent molecule
TEMPO in the hydrophobic environment of HDL can enhance its reaction
kinetics. From the observed results we can propose that HDL2 subfraction is
more efficient than HDL3 in promoting the reaction what could be related to
the difference in atherogenetic protection behaviour between these two
members of the lipoprotein particles family.
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SA@ETAK
Istra`ivanje kinetike lipidne faze u HDL s pomo}u ESR spektroskopije
Jasminka Brnjas-Kraljevi}, Marina Kveder, Greta Pifat,
Slavko Pe~ar i Milan Schara
Dvije subfrakcije lipoproteina velike gusto}e HDL2 i HDL3 ozna~ene su sa spin-
skom probom TEMPO koja ulazi i u vodenu i u lipidnu fazu. Dinamika lipidne faze
prou~avana je pra}enjem redukcijskih procesa ugra|ene probe TEMPO askorbins-
kom kiselinom. Redukcija paramagnetnog nitroksida u neparamagnetni hidroksilamin
uzrokuje vremensko smanjenje ESR signala. Krivulja redukcije upu}uje na slo`eni
proces, pri ~emu particijski koeficijent probe TEMPO ostaje nepromijenjen tijekom re-
akcije. Redukcijski procesi u otopini HDL br`i su od redukcijskih procesa u ~istim
otopinama spinske oznake i askorbinske kiseline. Predlo`en je model redukcije TEM-
PO s askorbinskom kiselinom u otopinama HDL. Pretpostavljeno je da su procesi,
koji se istovremeno doga|aju u tom slo`enom sistemu, odre|eni ukupnom brzinom
reakcije koja ovisi o lokalnim koncentracijama reaktanata kao i o transportnim oso-
binama ~estica u doti~noj fazi.
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